The impact of hypoxia on cell death pathways

Biochemical Society Transactions

Volumn 41, Issue 2, 2013, Pages 657-663

  Lenihan, Colin R ^a   Taylor, Cormac T ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Apoptosis; B cell lymphoma (Bcl); Hypoxia; Nuclear factor B (NF B).

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; DNA; FAS ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 1; PROTEIN BCL 2; PROTEIN BCL B; PROTEIN BCL XL; PROTEIN BID; PROTEIN BNIP3; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DAMAGE; CELL DEATH; CELL GROWTH; CELL HYPOXIA; CELL MATURATION; CELL PROLIFERATION; CELL STRESS; CELL VIABILITY; CONFERENCE PAPER; DNA DAMAGE; DNA REPAIR; HUMAN; HYPOXIA; IN VIVO STUDY; ONCOGENE C MYC; OXYGEN SUPPLY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEATH; CELL HYPOXIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; NF-KAPPA B; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84875395170     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120345     Document Type: Conference Paper

References (62)

1. Kerr, J.F., Wyllie, A.H. and Currie, A.R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257
2. Fuchs, Y. and Steller, H. Programmed cell death in animal development and disease. Cell 147, 742-758
3. Wajant, H. (2002) The Fas signaling pathway: more than a paradigm. Science 296, 1635-1636
4. Tait, S.W. and Green, D.R. (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 11, 621-632
5. Daniel, P.T., Schulze-Osthoff, K., Belka, C. and Guner, D. (2003) Guardians of cell death: the Bcl-2 family proteins. Essays Biochem. 39, 73-88
6. Danial, N.N. and Korsmeyer, S.J. (2004) Cell death: critical control points. Cell 116, 205-219
7. Kuwana, T., Mackey, M.R., Perkins, G., Ellisman, M.H., Latterich, M., Schneiter, R., Green, D.R. and Newmeyer, D.D. (2002) Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111, 331-342
8. Karbowski, M., Norris, K.L., Cleland, M.M., Jeong, S.Y. and Youle, R.J. (2006) Role of Bax and Bak in mitochondrial morphogenesis. Nature 443, 658-662
9. Letai, A., Bassik, M.C., Walensky, L.D., Sorcinelli, M.D., Weiler, S. and Korsmeyer, S.J. (2002) Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2, 183-192
10. Willis, S.N., Chen, L., Dewson, G., Wei, A., Naik, E., Fletcher, J.I., Adams, J.M. and Huang, D.C. (2005) Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 19, 1294-1305
11. Kurokawa, M. and Kornbluth, S. (2009) Caspases and kinases in a death grip. Cell 138, 838-854
12. Krammer, P.H., Arnold, R. and Lavrik, I.N. (2007) Life and death in peripheral T cells. Nat. Rev. Immunol. 7, 532-542
13. Li, H., Zhu, H., Xu, C.J. and Yuan, J. (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501
14. Van der Laarse, A. and Freud, G.E. (1975) Multiple measurement of intranural myocardial oxygen tension. Recent Adv. Stud. Card. Struct. Metab. 5, 441-447
15. Brezis, M. and Rosen, S. (1995) Hypoxia of the renal medulla: its implications for disease. N. Engl. J. Med. 332, 647-655
16. Kaelin, Jr., W.G. and Ratcliffe, P.J. (2008) Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30, 393-402
17. Maxwell, P.H., Wiesener, M.S., Chang, G.W., Clifford, S.C., Vaux, E.C., Cockman, M.E., Wykoff, C.C., Pugh, C.W., Maher, E.R. and Ratcliffe, P.J. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275
18. Jiang, B.H., Rue, E., Wang, G.L., Roe, R. and Semenza, G.L. (1996) Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271, 17771-17778
19. Koshiji, M., Kageyama, Y., Pete, E.A., Horikawa, I., Barrett, J.C. and Huang, L.E. (2004) HIF-1α induces cell cycle arrest by functionally counteracting Myc. EMBO J. 23, 1949-1956
20. Hu, C.J., Sataur, A., Wang, L., Chen, H. and Simon, M.C. (2007) The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1α and HIF-2α. Mol. Biol. Cell 18, 4528-4542
21. Paliege, A., Rosenberger, C., Bondke, A., Sciesielski, L., Shina, A., Heyman, S.N., Flippin, L.A., Arend, M., Klaus, S.J. and Bachmann, S. (2010) Hypoxia-inducible factor-2α-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization. Kidney Int. 77, 312-318
22. Gordan, J.D., Lal, P., Dondeti, V.R., Letrero, R., Parekh, K.N., Oquendo, C.E., Greenberg, R.A., Flaherty, K.T., Rathmell, W.K., Keith, B. et al. (2008) HIF-α effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell 14, 435-446
23. Karin, M. and Greten, F.R. (2005) NF-κB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749-759
24. Oliver, K.M., Garvey, J.F., Ng, C.T., Veale, D.J., Fearon, U., Cummins, E.P. and Taylor, C.T. (2009) Hypoxia activates NF-κB-dependent gene expression through the canonical signaling pathway. Antioxid. Redox Signaling 11, 2057-2064
25. Cummins, E.P., Berra, E., Comerford, K.M., Ginouves, A., Fitzgerald, K.T., Seeballuck, F., Godson, C., Nielsen, J.E., Moynagh, P., Pouyssegur, J. and Taylor, C.T. (2006) Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NF-κB activity. Proc. Natl. Acad. Sci. U.S.A. 103, 18154-18159
26. Shimizu, S., Eguchi, Y., Kamiike, W., Itoh, Y., Hasegawa, J., Yamabe, K., Otsuki, Y., Matsuda, H. and Tsujimoto, Y. (1996) Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res. 56, 2161-2166
27. Papandreou, I., Krishna, C., Kaper, F., Cai, D., Giaccia, A.J. and Denko, N.C. (2005) Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. Cancer Res. 65, 3171-3178
28. Weinmann, M., Jendrossek, V., Handrick, R., Guner, D., Goecke, B. and Belka, C. (2004) Molecular ordering of hypoxia-induced apoptosis: critical involvement of the mitochondrial death pathway in a FADD/caspase-8 independent manner. Oncogene 23, 3757-3769
29. Leonard, M.O., Cottell, D.C., Godson, C., Brady, H.R. and Taylor, C.T. (2003) The role of HIF-1α in transcriptional regulation of the proximal tubular epithelial cell response to hypoxia. J. Biol. Chem. 278, 40296-40304
30. Schmaltz, C., Hardenbergh, P.H., Wells, A. and Fisher, D.E. (1998) Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol. Cell. Biol. 18, 2845-2854
31. Kim, J.Y., Ahn, H.J., Ryu, J.H., Suk, K. and Park, J.H. (2004) BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1α. J. Exp. Med. 199, 113-124
32. Carmeliet, P., Dor, Y., Herbert, J.M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P. et al. (1998) Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485-490
33. Papandreou, I., Cairns, R.A., Fontana, L., Lim, A.L. and Denko, N.C. (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3, 187-197
34. Kilic, M., Kasperczyk, H., Fulda, S. and Debatin, K.M. (2007) Role of hypoxia inducible factor-1α in modulation of apoptosis resistance. Oncogene 26, 2027-2038
35. Sullivan, R., Pare, G.C., Frederiksen, L.J., Semenza, G.L. and Graham, C.H. (2008) Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity. Mol. Cancer Ther. 7, 1961-1973
36. Ryan, H.E., Lo, J. and Johnson, R.S. (1998) HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J. 17, 3005-3015
37. Liao, D., Corle, C., Seagroves, T.N. and Johnson, R.S. (2007) Hypoxia-inducible factor-1α is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res. 67, 563-572
38. Unruh, A., Ressel, A., Mohamed, H.G., Johnson, R.S., Nadrowitz, R., Richter, E., Katschinski, D.M. and Wenger, R.H. (2003) The hypoxia-inducible factor-1α is a negative factor for tumor therapy. Oncogene 22, 3213-3220
39. Semenza, G.L. Hypoxia-inducible factors in physiology and medicine. Cell 148, 399-408
40. Sowter, H.M., Ratcliffe, P.J., Watson, P., Greenberg, A.H. and Harris, A.L. (2001) HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res. 61, 6669-6673
41. Fei, P., Wang, W., Kim, S.H., Wang, S., Burns, T.F., Sax, J.K., Buzzai, M., Dicker, D.T., McKenna, W.G., Bernhard, E.J. and El-Deiry, W.S. (2004) Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth. Cancer Cell 6, 597-609
42. Yasuda, M., Theodorakis, P., Subramanian, T. and Chinnadurai, G. (1998) Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence. J. Biol. Chem. 273, 12415-12421
43. Bellot, G., Garcia-Medina, R., Gounon, P., Chiche, J., Roux, D., Pouyssegur, J. and Mazure, N.M. (2009) Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol. Cell. Biol. 29, 2570-2581
44. Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X.H., Mizushima, N., Packer, M., Schneider, M.D. and Levine, B. (2005) Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122, 927-939
45. Erler, J.T., Cawthorne, C.J., Williams, K.J., Koritzinsky, M., Wouters, B.G., Wilson, C., Miller, C., Demonacos, C., Stratford, I.J. and Dive, C. (2004) Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance. Mol. Cell. Biol. 24, 2875-2889
46. Chen, N., Chen, X., Huang, R., Zeng, H., Gong, J., Meng, W., Lu, Y., Zhao, F., Wang, L. and Zhou, Q. (2009) BCL-xL is a target gene regulated by hypoxia-inducible factor-1α. J. Biol. Chem. 284, 10004-10012
47. Aylon, Y. and Oren, M. (2007) Living with p53, dying of p53. Cell 130, 597-600
48. An, W.G., Kanekal, M., Simon, M.C., Maltepe, E., Blagosklonny, M.V. and Neckers, L.M. (1998) Stabilization of wild-type p53 by hypoxia-inducible factor 1α. Nature 392, 405-408
49. Koumenis, C., Alarcon, R., Hammond, E., Sutphin, P., Hoffman, W., Murphy, M., Derr, J., Taya, Y., Lowe, S.W., Kastan, M. and Giaccia, A. (2001) Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol. Cell. Biol. 21, 1297-1310
50. Menrad, H., Werno, C., Schmid, T., Copanaki, E., Deller, T., Dehne, N. and Brune, B. Roles of hypoxia-inducible factor-1α (HIF-1α) versus HIF-2α in the survival of hepatocellular tumor spheroids. Hepatology 51, 2183-2192
51. Roberts, A.M., Watson, I.R., Evans, A.J., Foster, D.A., Irwin, M.S. and Ohh, M. (2009) Suppression of hypoxia-inducible factor 2α restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells. Cancer Res. 69, 9056-9064
52. Biswas, S., Troy, H., Leek, R., Chung, Y.L., Li, J.L., Raval, R.R., Turley, H., Gatter, K., Pezzella, F., Griffiths, J.R. et al. (2010) Effects of HIF-1α and HIF2α on growth and metabolism of clear-cell renal cell carcinoma 786-0 xenografts. J. Oncol. 2010, 757908
53. Fan, Y., Dutta, J., Gupta, N., Fan, G. and Gelinas, C. (2008) Regulation of programmed cell death by NF-κB and its role in tumorigenesis and therapy. Adv. Exp. Med. Biol. 615, 223-250
54. Davis, R.J. (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252
55. Papa, S., Bubici, C., Zazzeroni, F., Pham, C.G., Kuntzen, C., Knabb, J.R., Dean, K. and Franzoso, G. (2006) The NF-κB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ. 13, 712-729
56. Javelaud, D. and Besancon, F. (2001) NF-κB activation results in rapid inactivation of JNK in TNFα-treated Ewing sarcoma cells: a mechanism for the anti-Apoptotic effect of NF-κB. Oncogene 20, 4365-4372
57. Kucharczak, J., Simmons, M.J., Fan, Y. and Gelinas, C. (2003) To be, or not to be: NF-κB is the answer -role of Rel/NF-κB in the regulation of apoptosis. Oncogene 22, 8961-8982
58. Wright, C.W. and Duckett, C.S. (2005) Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function. J. Clin. Invest. 115, 2673-2678
59. Deveraux, Q.L., Roy, N., Stennicke, H.R., Van Arsdale, T., Zhou, Q., Srinivasula, S.M., Alnemri, E.S., Salvesen, G.S. and Reed, J.C. (1998) IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17, 2215-2223
60. Sangeetha, M., Pillai, M.S., Philip, L., Lakatta, E.G. and Shivakumar, K. NF-κB inhibition compromises cardiac fibroblast viability under hypoxia. Exp. Cell Res. 317, 899-909
61. Tergaonkar, V., Pando, M., Vafa, O., Wahl, G. and Verma, I. (2002) p53 stabilization is decreased upon NF-κB activation: a role for NF-κB in acquisition of resistance to chemotherapy. Cancer Cell 1, 493-503
62. Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A.S., Nizet, V., Johnson, R.S., Haddad, G.G. and Karin, M. (2008) NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 453, 807-811